Mar 22 | Mar 21 | Mar 20 | Mar 19 | Mar 16 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 14.88M | $ 9.02M | $ 1.65M | $ 3.21M | $ 3.41M |
Total Assets | $ 70.58M | $ 57.86M | $ 46.40M | $ 52.78M | $ 43.83M |
Total Debt | $ 17.03M | $ 18.64M | $ 30.74M | $ 30.49M | $ 27.34M |
Net Debt | $ 2.15M | $ 9.62M | $ 29.09M | $ 27.27M | $ 23.92M |
Total Liabilities | $ 34.51M | $ 30.32M | $ 36.19M | $ 39.71M | $ 32.35M |
Stockholders Equity | $ 36.07M | $ 27.53M | $ 10.21M | $ 13.07M | $ 11.48M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |